HBIO

Harvard Bioscience Inc.

NasdaqAdd to watchlist

Healthcare · Medical Instruments & Supplies

$8.03

+$0.06+0.75%

Delayed · 2026-09-17T20:00:00.000Z · marketstack

Aug 24, 2026$8.03

+$0.48+6.36%over 1M

Session

Day range28% of range

$7.97$8.19

Fundamentals

Visualize fundamentals and more

Market cap: 36.34M
P/E ratio: -

Revenue grew −8.06% in FY2025, +16.92% slower than its sector. The median across Healthcare companies this platform tracks is +8.87%.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

Debt covenants
Currency moves
Litigation
Commodity prices
Cybersecurity
Export controls
Inflation
Tariffs

And 15 more.

Debt covenants
As of December 31, 2025, we had outstanding borrowings of $40 million under the Credit Agreement. 8 Table of Contents Pursuant to the terms of the Credit Agreement, we are subject to various covenants, including negative covenants that restrict our ability to …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

25 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 17, 2026 · the last close

Harvard Bioscience Inc. investor relations

What HBIO has filed with the SEC. This is not Harvard Bioscience Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Harvard Bioscience Inc.

Also filed under Medical Instruments & Supplies, ranked by how closely they sit beside HBIO.

ISRGIntuitive Surgical Inc.compare with HBIO
BDXBecton Dickinson & Co.compare with HBIO
COO

What an account lets you do with Harvard Bioscience Inc.

Be told the moment a HBIO insider trades
Put Harvard Bioscience Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Harvard Bioscience Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Harvard Bioscience Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

Debt covenants
Currency moves
Litigation
Commodity prices
Cybersecurity
Export controls
Inflation
Tariffs

And 15 more.

Debt covenants
As of December 31, 2025, we had outstanding borrowings of $40 million under the Credit Agreement. 8 Table of Contents Pursuant to the terms of the Credit Agreement, we are subject to various covenants, including negative covenants that restrict our ability to …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Session

Fundamentals

What it says it is exposed to

Recent activity

Discussion

Harvard Bioscience Inc. investor relations

Companies like Harvard Bioscience Inc.

Ask about Harvard Bioscience Inc.

What an account lets you do with Harvard Bioscience Inc.

Recent activity

What it says it is exposed to